Suppr超能文献

使用 HiBiT 进行抗体非依赖性巨细胞病毒病毒粒子蛋白掺入的定量分析。

Antibody-Independent Quantification of Cytomegalovirus Virion Protein Incorporation Using HiBiT.

机构信息

The Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR, USA.

出版信息

Methods Mol Biol. 2021;2244:213-232. doi: 10.1007/978-1-0716-1111-1_11.

Abstract

Human cytomegalovirus (HCMV) is a large double-stranded DNA virus and member of the β-herpesvirus family. HCMV is ubiquitous in the human population and causes lifelong infections. HCMV infection is associated with high morbidity and mortality in immunocompromised individuals and the virus is a major cause of virus-mediated congenital disease. There have been a number of HCMV entry receptors identified that use one of two viral receptor binding complexes, including the gH/gL/gO complex and the pentamer made up of gH/gL/UL128/UL130/UL131a. Cytomegaloviruses (CMVs) are typically host-restricted requiring the use of species-specific modeling and culture conditions. We use rat CMV (RCMV) to study CMV-accelerated vascular disease and chronic allograft rejection. RCMV encodes homologous versions of the entry complex proteins but their incorporation and copy number per virion are still unknown. In this methods article, we describe a novel approach of HiBiT tagging viral proteins in order to detect and quantify protein incorporation into particles. This method is independent of protein-specific antibodies and can be standardized using a commercially available HiBiT protein standard. Using bacterial artificial chromosome (BAC) recombineering, we have constructed two individual viruses containing a HiBiT tag fused to the C'-terminus of either the UL128 homolog (R129) or the UL130 homolog (R131). Viruses containing these mutations were rescued, purified and analyzed. Our data demonstrate that R129 and R131 are both incorporated into RCMV virions at equimolar ratios relative to genome copy number, supporting this antibody-free approach for quantifying viral protein incorporation and its application toward the identification of domains required for incorporation.

摘要

人巨细胞病毒(HCMV)是一种大型双链 DNA 病毒,属于β疱疹病毒家族。HCMV 在人群中普遍存在,导致终身感染。HCMV 感染与免疫功能低下个体的高发病率和死亡率有关,该病毒是病毒介导的先天性疾病的主要原因。已经确定了一些 HCMV 进入受体,它们使用两种病毒受体结合复合物之一,包括 gH/gL/gO 复合物和由 gH/gL/UL128/UL130/UL131a 组成的五聚体。巨细胞病毒(CMVs)通常具有宿主限制性,需要使用特定于物种的建模和培养条件。我们使用大鼠 CMV(RCMV)来研究 CMV 加速的血管疾病和慢性同种异体移植排斥反应。RCMV 编码进入复合物蛋白的同源版本,但它们的掺入和每个病毒粒子的拷贝数仍不清楚。在本方法文章中,我们描述了一种新的 HiBiT 标记病毒蛋白的方法,以检测和量化蛋白掺入颗粒。该方法不依赖于蛋白特异性抗体,并且可以使用商业上可获得的 HiBiT 蛋白标准进行标准化。通过细菌人工染色体(BAC)重组,我们构建了两种单独的病毒,其中一种包含 HiBiT 标签融合到 UL128 同源物(R129)或 UL130 同源物(R131)的 C'-末端。含有这些突变的病毒被拯救、纯化和分析。我们的数据表明,R129 和 R131 都以相对于基因组拷贝数的等摩尔比掺入 RCMV 病毒粒子中,支持这种无抗体方法来量化病毒蛋白的掺入及其在鉴定掺入所需结构域中的应用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验